Key result
Glycoprotein acetyls linked to ~23% higher risk of incident diabetic kidney disease.
Why the study?
The renal handling and catabolism of major HDL protein components, specifically apolipoproteins A-I, A-IV, and A-II, were not fully understood, particularly the kidney's role in their metabolism.
Cohort (n=18,287)
Yes
Answers are grounded in this paper and cite their sources.
Suggests renal catabolism of apoA-I and A-IV; hypothesis-generating for dyslipidemia mechanisms and requires validation.
Renal handling of major HDL components was studied by analyzing urine from patients with Fanconi syndrome, a rare renal proximal tubular reabsorption failure, including dysfunction of the kidney HDL receptor, cubilin. A high urinary excretion of apolipoprotein A-I and A-IV corresponding to a major part of the metabolism of these proteins was measured. In contrast, no urinary excretion of apolipoprotein A-II which is more hydrophobic and tighter bound to HDL was found. Control urines displayed absence of the three apolipoproteins. Urinary excretion of phospholipids, triglycerides, cholesterol and cholesterol esters in patients was as low as in controls. In conclusion, these data indicate that the human kidney is a major site for filtered nascent apolipoprotein A-I and A-IV but not for HDL particles.
No takes yet. Share an insight, caveat, or question.
Graversen et al. (2008) conducted a cohort in Diabetic Kidney Disease (n=18,287). Lifestyle factors and metabolic biomarkers vs. Reference categories of lifestyle factors / biomarker levels was evaluated on Incident Diabetic Kidney Disease (association with glycoprotein acetyls) (HR 1.23, 95% CI 1.17-1.28, p=<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: